CVS Health quarterly sales rise 4% on pharmacy boost
Sales rose to $69.55B from $66.89B
Yardeni Research President Ed Yardeni argues a V-shaped recovery has taken shape in the U.S. due to 'an extraordinary amount of monetary stimulus and fiscal stimulus.'
CVS Health Corp reported a 4% rise in fourth-quarter sales on Tuesday, helped in part by COVID-19 testing at its pharmacies.
CLICK HERE TO READ MORE ON FOX BUSINESS
| Ticker | Security | Last | Change | Change % |
|---|---|---|---|---|
| CVS | CVS HEALTH CORP. | 56.75 | -0.08 | -0.14% |
However, the company’s profit fell in the quarter ended Dec. 31, hurt by higher costs at its health insurance unit.
CVS employee (CVS)
Last year, as people avoided visiting hospitals for scheduled procedures due to the pandemic, health insurers benefited from lower costs. But now, with COVID-19 vaccinations underway, non-urgent procedures are expected to bounce back to normal levels, leading to higher costs for health insurers.
GET FOX BUSINESS ON THE GO BY CLICKING HERE
CVS Health’s net profit fell to $973 million, or 74 cents per share, in the reported quarter, from $1.75 billion, or $1.33 per share, a year earlier.
Sales rose to $69.55 billion from $66.89 billion.
The company expects 2021 adjusted profit of between $7.39 to $7.55 per share, compared with analysts’ estimates of $7.54 per share, according to IBES data from Refinitiv.